Related Experiment Video
Updated: Nov 15, 2025
Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification
Published on: March 31, 2021
Droplet digital PCR as a novel dia-gnostic tool
Background:
Nowadays, modern treatment methods for cancer patients are based on targeting specific molecules involved in cellular signaling system associated with tumor initiation and progression. The success of such approach depends on a correctly chosen dia-gnostic test with high sensitivity that identifies the occurrence and level of bio-markers in patients to select those who will respond and benefit from the treatment. The development of new technologies and the upgrades of the known ones contribute to the innovations in molecular characterization of cancer, which allows the detection of patients mutational status with high sensitivity and specificity.
Purpose:
Here, we discuss the utilization of the third-generation type of polymerase chain reaction (PCR), droplet digital PCR (ddPCR), in the molecular dia-gnostics of oncology diseases. According to the studies reported in our review, ddPCR represents a promising tool in genetic profiling of cancer patients. Therefore, the optimization and precise validation may enable gradual implementation of ddPCR into clinical practice in the field of oncology.
Insights
Droplet digital PCR (ddPCR) offers a sensitive method for cancer patient genetic profiling. Further validation could integrate this advanced polymerase chain reaction (PCR) technique into routine oncology diagnostics.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Modern cancer treatments target specific molecules in tumor signaling pathways.
- Accurate diagnostic tests are crucial for identifying patients who will benefit from targeted therapies.
- Advancements in molecular characterization improve the detection of cancer biomarkers.
Purpose of the Study:
- To review the application of droplet digital PCR (ddPCR), a third-generation polymerase chain reaction (PCR) technology, in oncology.
- To highlight ddPCR's potential as a tool for molecular diagnostics in cancer patients.
- To discuss the prospects of integrating ddPCR into clinical oncology practice.
Main Methods:
- Review of existing studies on droplet digital PCR (ddPCR) in cancer diagnostics.
- Analysis of ddPCR's capabilities in genetic profiling.
- Discussion of validation and optimization requirements for clinical implementation.
Main Results:
- Droplet digital PCR (ddPCR) shows promise for sensitive and specific genetic profiling in oncology.
- The technology enables precise detection of cancer-related mutations.
- Existing literature supports ddPCR as a valuable tool for molecular diagnostics.
Conclusions:
- Droplet digital PCR (ddPCR) is a powerful technique for molecular diagnostics in oncology.
- Optimization and validation are key steps for its adoption in clinical settings.
- ddPCR has the potential to significantly advance cancer patient management.
More Related Videos
08:23Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
Published on: September 25, 2018
06:38Droplet Digital TRAP ddTRAP: Adaptation of the Telomere Repeat Amplification Protocol to Droplet Digital Polymerase Chain Reaction
Published on: May 3, 2019